Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Brain Res Bull ; 75(5): 674-80, 2008 Mar 28.
Artigo em Inglês | MEDLINE | ID: mdl-18355645

RESUMO

The purpose of the present study was to investigate the 5-HT(2C) receptor-mediated effects on the spinal monosynaptic mass reflex activities and also its functional interactions with 5-HT(1A) receptors in anesthetized, acutely spinalized mammalian adult spinal cord in vivo. Intravenous administration of (+/-)-2,5-dimethoxy-4-iodoamphetamine hydrochloride (DOI) (0.1 mg/kg), an agonist of 5-HT(2A/2C) receptors, significantly increased the excitability of spinal motoneurons as reflected by an increase in the spinal monosynaptic mass reflex amplitude to 150-200% of the control. 5-HT(2A/2C) receptor-induced motoneuron excitability was slow, persistent and long-lasting for more than 2h that was significantly inhibited by 5-HT(2C) receptor specific antagonist SB 242084 administered 10 min prior to DOI. Simultaneous administration of DOI (0.1 mg/kg, i.v.) along with (+/-)-8-hydroxy dipropylaminotetraline hydrobromide (8-OH-DPAT) (0.1 mg/kg, i.v.) completely inhibited DOI-induced spinal monosynaptic mass reflex facilitation. In another separate study, administration of 8-OH-DPAT (0.1 mg/kg, i.v.) at the maximum response of DOI also inhibited the motoneuron's excitability; however, the inhibition lasted only for a period of 40-60 min after administration of 8-OH-DPAT, after which the spinal monosynaptic mass reflex amplitude reached its maximum level. These findings suggest that the 5-HT(2C) receptor is primarily involved in the mediation of the long-lasting excitability of spinal motoneurons and possibly interacts with its functional counterpart, 5-HT(1A) receptors in the mammalian adult spinal cord.


Assuntos
Receptor 5-HT1A de Serotonina/fisiologia , Receptor 5-HT2C de Serotonina/fisiologia , Reflexo Monosináptico/fisiologia , Medula Espinal/fisiologia , 8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Aminopiridinas/farmacologia , Anfetaminas/farmacologia , Animais , Interações Medicamentosas , Estimulação Elétrica/métodos , Indóis/farmacologia , Região Lombossacral , Masculino , Potenciais da Membrana/efeitos dos fármacos , Potenciais da Membrana/fisiologia , Potenciais da Membrana/efeitos da radiação , Neurônios Motores/efeitos dos fármacos , Neurônios Motores/fisiologia , Neurônios Motores/efeitos da radiação , Ratos , Ratos Wistar , Reflexo Monosináptico/efeitos dos fármacos , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia , Medula Espinal/citologia , Medula Espinal/efeitos dos fármacos , Medula Espinal/efeitos da radiação
2.
Prog Neuropsychopharmacol Biol Psychiatry ; 31(7): 1449-55, 2007 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-17688988

RESUMO

The effects of 7- and 21-day haloperidol treatment on the spinal serotonergic system were examined in vivo in acutely spinalized adult rats. Intravenous administration of a selective 5-HT(2A/2C) receptor agonist, (+/-)-2,5-Dimethoxy-4-iodoamphetamine hydrochloride (0.1 mg/kg) significantly increased the excitability of spinal motoneurones as reflected by increased monosynaptic mass reflex amplitude. This was significantly reduced in rats treated with haloperidol (1 mg/kg/day, i.p.) for 7 and 21 days. Administration of a 5-HT(1A/7) receptor agonist, (+/-)-8-Hydroxy dipropylaminotetraline hydrobromide (0.1 mg/kg, i.v.) significantly inhibited the monosynaptic mass reflex. This inhibition was greatly prolonged in haloperidol treated animals. These results demonstrate that the effects of haloperidol on the activation and desensitization of 5-HT(1A) and 5-HT(2A/2C) receptors respectively, may be mediated via intracellular mechanisms shared by these receptors with dopamine D(2) receptors in the mammalian spinal cord. The above serotonergic mechanisms may be partly responsible for haloperidol-induced extrapyramidal motor dysfunction.


Assuntos
Antipsicóticos/farmacologia , Discinesia Induzida por Medicamentos/fisiopatologia , Haloperidol/farmacologia , Agonistas do Receptor 5-HT1 de Serotonina , Antagonistas do Receptor 5-HT2 de Serotonina , Medula Espinal/fisiologia , 8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Anfetaminas/farmacologia , Animais , Eletrofisiologia , Masculino , Ratos , Ratos Wistar , Receptores de Dopamina D2/efeitos dos fármacos , Reflexo Monosináptico/efeitos dos fármacos , Agonistas do Receptor de Serotonina/farmacologia , Medula Espinal/efeitos dos fármacos
3.
Neuroreport ; 17(12): 1309-12, 2006 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-16951575

RESUMO

Serotonin modulates neurotransmission at synapses between various spinal neurons and, thus, may either facilitate or depress the information processed in the circuits and ultimately modulate the final motor output. A possible neuromodulatory role of 5-hydroxytryptamine type 1A (5-HT1A) receptors on the excitability of lumbar spinal Renshaw cells was explored in anesthetized rats spinalized at T4 level. Intravenous administration of the specific 5-HT1A agonist (2R)-(+)-8-hydroxy-2-(di-n-propylamino)tetralin hydrobromide (8-OH-DPAT) (0.1 mg/kg) decreased the Renshaw cell burst response by 20-45%. This effect was completely antagonized by the specific 5-HT1A antagonist (S)-N-tert-butyl-3-(4-(2-methoxyphenyl)-piperazin-1-yl)-2-phenylpropanamide dihydrochloride [(S)-WAY 100135] (0.1 mg/kg, intravenous), although this drug per se had no effect on the Renshaw cell burst response. These results suggest that 8-OH-DPAT-induced decrease in Renshaw cell burst firing was mediated by 5-HT1A receptors located either presynaptically or postsynaptically.


Assuntos
Potenciais de Ação/fisiologia , Interneurônios/fisiologia , Receptor 5-HT1A de Serotonina/fisiologia , Medula Espinal/citologia , 8-Hidroxi-2-(di-n-propilamino)tetralina/farmacologia , Potenciais de Ação/efeitos dos fármacos , Animais , Interações Medicamentosas , Interneurônios/efeitos dos fármacos , Região Lombossacral , Masculino , Piperazinas/farmacologia , Ratos , Ratos Sprague-Dawley , Antagonistas da Serotonina/farmacologia , Agonistas do Receptor de Serotonina/farmacologia
4.
J Neurosci Res ; 80(2): 203-10, 2005 Apr 15.
Artigo em Inglês | MEDLINE | ID: mdl-15765528

RESUMO

The present study examined the effects of unilateral 6-hydroxydopamine (6-OHDA) lesions of the substantia nigra pars compacta (SNc) on electrophysiological properties of subthalamic neurons (STN) in adult rats. Most neurons displayed regular spontaneous tonic firing patterns in both control and lesioned animals; however, the percentage of neurons with spontaneous burst firing at hyperpolarized membrane potentials was increased significantly in lesioned animals compared with controls (45% vs. 14% respectively). In the presence of bicuculline, a gamma-aminobutyric acid type A (GABAA) receptor antagonist, electrical stimulation of the internal capsule produced monosynaptic excitatory postsynaptic potentials (EPSPs) in almost all recorded neurons. DA (50 microM) increased the amplitude and/or duration of the EPSPs in neurons from both groups, whereas the DA D1 receptor agonist SKF 81297 (10 microM) produced a significant increase in amplitude and/or duration of EPSPs in neurons from the lesioned group only. This latter increase was blocked by pretreatment with the DA D1 antagonist SCH 23390 (10 microM). These data suggest that unilateral degeneration of DA neurons in the SNc changes firing properties and enhances electrophysiological responsiveness of STN neurons to activation of DA D1 receptors.


Assuntos
Dopamina/metabolismo , Neurônios/fisiologia , Núcleo Subtalâmico/fisiologia , Potenciais de Ação/efeitos dos fármacos , Potenciais de Ação/fisiologia , Animais , Benzazepinas/farmacologia , Eletrofisiologia , Masculino , Neurônios/efeitos dos fármacos , Ratos , Ratos Sprague-Dawley , Núcleo Subtalâmico/efeitos dos fármacos
5.
J Biol Chem ; 278(44): 43628-35, 2003 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-12930822

RESUMO

Loss-of-function mutations in parkin are the major cause of early-onset familial Parkinson's disease. To investigate the pathogenic mechanism by which loss of parkin function causes Parkinson's disease, we generated a mouse model bearing a germline disruption in parkin. Parkin-/- mice are viable and exhibit grossly normal brain morphology. Quantitative in vivo microdialysis revealed an increase in extracellular dopamine concentration in the striatum of parkin-/- mice. Intracellular recordings of medium-sized striatal spiny neurons showed that greater currents are required to induce synaptic responses, suggesting a reduction in synaptic excitability in the absence of parkin. Furthermore, parkin-/- mice exhibit deficits in behavioral paradigms sensitive to dysfunction of the nigrostriatal pathway. The number of dopaminergic neurons in the substantia nigra of parkin-/- mice, however, is normal up to the age of 24 months, in contrast to the substantial loss of nigral neurons characteristic of Parkinson's disease. Steady-state levels of CDCrel-1, synphilin-1, and alpha-synuclein, which were identified previously as substrates of the E3 ubiquitin ligase activity of parkin, are unaltered in parkin-/- brains. Together these findings provide the first evidence for a novel role of parkin in dopamine regulation and nigrostriatal function, and a non-essential role of parkin in the survival of nigral neurons in mice.


Assuntos
Encéfalo/patologia , Dopamina/metabolismo , Ubiquitina-Proteína Ligases/genética , Ubiquitina-Proteína Ligases/fisiologia , Alelos , Animais , Comportamento Animal , Western Blotting , Encéfalo/metabolismo , Cromatografia Líquida de Alta Pressão , Modelos Animais de Doenças , Eletrofisiologia , Mutação em Linhagem Germinativa , Camundongos , Camundongos Transgênicos , Modelos Genéticos , Neurônios/metabolismo , Doença de Parkinson/genética , Receptores Dopaminérgicos/metabolismo , Substância Negra/metabolismo , Fatores de Tempo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...